Freely Filtered 059: Another dogma shredding trial about diuretics, this time torsemide goes up against king furosemide and its ability to prevent rehospitalization CV events.
Freely Filtered 060: Hydrochlorothiazide has long been said to prevent calcium-based kidney stones and then a well done blinded trial showed, that it’s complicated. Join The Filtrate for a masterclass on this landmark trial.
Freely Filtered 056: MYTEMP is the largest dialysis trial. 15,000 patients, 4.3 million dialysis treatments. We bring in lead PI Amit Garg to help break it down the trial and its implications.
Freely Filtered 055: STOP-ACE is an ambitious RCT that attempts to answer the question, “Should we stop the ACE inhibitor when the GFR gets low?” The filtrate bring in Laurie Tomlinson to bulk up our discussion.
Freely Filtered 054: EMPA-Kidney. EMPA-Kidney is the last of the big three to report their Kidney Endpoints SGLT2i trial (CREDENCE for Cana, DAPA-CKD for Dapa, and now EMPA-Kidney for Empa) and it answers some questions that had previously been unanswered. Join the Filtrate as they tear it apart.
Freely Filtered 051: ADVOR turns the practice of sequential nephron blockade on its head by blocking the proximal tubule before the loop of Henle. Does it work? Join The Filtrate as we dissect the latest diuretic RCT.